Taastrup, Denmark). Inclusions were enumerated by fluorescence microscopy observing at least 20 individual fields of vision for each well. Statistical analysis Statistical analysis was done using GraphPad Prism 4. Medians of vaginal chlamydial load were analyzed using Kruskall-Wallis followed by Dunn’s post test. A value of P,0.05 was considered statistically significant. Supporting Information Figure S1 Genital tract tissue (representative of 4 individually mice) was isolated from CD4- depleted and non-depleted i.n MoPn infected mice and surface stained using a FITC conjugated References 1. WHO (2001) Global Prevalence and Incidence of selected Curable Sexually Transmitted Infections:Overview and Estimates. In World Health Organization, Geneva, Switzerland. 2. ECDC (2008) Annual Epidemiological Report on Communicable Diseases in Europe, European Centre for Disease Prevention and Control. 3. Paavonen J, Eggert-Kruse W (1999) Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 5: 433–447. 4. Brunham RC, Kimani J, Bwayo J, Maitha G, Maclean I, et al. (1996) The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis 173: 950–956. 5. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, et al. (2000) Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85: 35–39. 6. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, et al. (2005) Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162: 668–675. 7. Wang SP, Grayston JT, Alexander ER (1967) Trachoma vaccine studies in monkeys. Am J Ophthalmol 63 :Suppl: 1615–1630. 8. Grayston JT, Wang SP, Woolridge RL, Alexander ER (1964) Prevention of Trachoma with Vaccine. Arch Environ Health 8: 518–526. 9. Brunham RC, Peeling RW (1994) Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 3: 218–233. 10. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, et al. (1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754–759. 11. Hafner LM, McNeilly C (2008) Vaccines for Chlamydia infections of the female genital tract. Future Microbiol 3: 67–77. 12. Su H, Caldwell HD (1995) CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun 63: 3302–3308. 13. Perry LL, Feilzer K, Caldwell HD (1997) Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 158: 3344–3352. 14. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843–850. 15. Wille-Reece U, Flynn BJ, Lore K, Koup RA, Miles AP, et al. (2006) Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J Exp Med 203: 1249–1258. 16. Beveridge NE, Price DA, Casazza JP, Pathan AA, Sander CR, et al. (2007) Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol 37: 3089–3100. 17. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR (2007) Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 81: 8468–8476. 18. Kannanganat S, Kapogiannis BG, Ibegbu C, Chennareddi L, Goepfert P, et al. (2007) Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J Virol 81: 12071–12076. 19. Rank RG, Batteiger BE (1989) Protective role of serum antibody in immunity to chlamydial genital infection. Infect Immun 57: 299–301. 20. Morrison SG, Morrison RP (2001) Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun 69: 2643–2649. 21. Morrison SG, Morrison RP (2005) The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A. Infect Immun 73: 6183–6186. 22. Murthy AK, Chaganty BK, Li W, Guentzel MN, Chambers JP, et al. (2009) A limited role for antibody in protective immunity induced by rCPAF and CpG CTH1 Anti-Chlamydial Vaccine anti-CD4 antibody (clone RM4-4), a PE conjugated anti-CD8 antibody (clone 53-6.7) and a APC conjugated anti-CD3 (clone 145-2C11) antibody. Found at: doi:10.1371/journal.pone.0010768.s001 (0.04 MB TIF) Acknowledgments We thank Vita Skov and Lisbeth Abrahamsen for excellent technical assistance. Author Contributions Conceived and designed the experiments: AWO MT PA. Performed the experiments: AWO. Analyzed the data: AWO PA. Contributed reagents/ materials/analysis tools: MT DC FF. Wrote the paper: AWO FF PA. vaccination against primary genital Chlamydia muridarum challenge. FEMS Immunol Med Microbiol 55: 271–279. 23. Sun G, Pal S, Weiland J, Peterson EM, de la Maza LM (2009) Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Vaccine. 24. Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, et al. (2002) Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105: 213–221. 25. Olsen AW, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P (2001) Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 69: 2773–2778. 26. Follmann F, Olsen AW, Jensen KT, Hansen PR, Andersen P, et al. (2008) Antigenic profiling of a Chlamydia trachomatis gene-expression library. J Infect Dis 197: 897–905. 27. Olsen AW, Follmann F, Jensen K, Hojrup P, Leah R, et al. (2006) Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection. J Infect Dis 194: 1258–1266. 28. Davidsen J, Rosenkrands I, Christensen D, Vangala A, Kirby D, et al. (2005) Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,69-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses. Biochim Biophys Acta 1718: 22–31. 29. Agger EM, Rosenkrands I, Hansen J, Brahimi K, Vandahl BS, et al. (2008) Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS ONE 3: e3116. 30. Hansen J, Jensen KT, Follmann F, Agger EM, Theisen M, et al. (2008) Liposome Delivery of Chlamydia muridarum Major Outer Membrane Protein Primes a Th1 Response That Protects against Genital Chlamydial Infection in a Mouse Model. J Infect Dis 198: 758–767. 31. Rank R (1999) In: Chlamydia Intracellular Biology, Pathogenesis and Immunity. Washington DC: ASM Press. pp 239–296. 32. Morrison RP, Caldwell HD (2002) Immunity to murine chlamydial genital infection. Infect Immun 70: 2741–2751. 33. Pal S, Fielder TJ, Peterson EM, de la Maza LM (1994) Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 62: 3354–3362. 34. Hu H, Huston G, Duso D, Lepak N, Roman E, et al. (2001) CD4(+) T cell effectors can become memory cells with high efficiency and without further division. Nat Immunol 2: 705–710. 35. Dooms H, Kahn E, Knoechel B, Abbas AK (2004) IL-2 induces a competitive survival advantage in T lymphocytes. J Immunol 172: 5973–5979. 36. Rank RG, Ramsey KH, Pack EA, Williams DM (1992) Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect.Immun 60: 4427–4429. 37. Goodall JC, Yeo G, Huang M, Raggiaschi R, Gaston JS (2001) Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library. Eur J Immunol 31: 1513–1522. 38. Barker CJ, Beagley KW, Hafner LM, Timms P (2008) In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Vaccine 26: 1285–1296. 39. Karunakaran KP, Rey-Ladino J, Stoynov N, Berg K, Shen C, et al. (2008) Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol 180: 2459–2465. 40. Yu H, Jiang X, Shen C, Karunakaran KP, Brunham RC (2009) Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models. J Immunol 182: 1602–1608. 41. Allen JE, Stephens RS (1989) Identification by sequence analysis of two-site posttranslational processing of the cysteine-rich outer membrane protein 2 of Chlamydia trachomatis serovar L2. J Bacteriol 171: 285–291. PLoS ONE | www.plosone.org 10 May 2010 | Volume 5 | Issue 5 | e10768